Bausch Health Companies Inc (NYSE:BHC)’s traded shares stood at 2.15 million during the last session, with the company’s beta value hitting 0.91. At the close of trading, the stock’s price was $8.60, to imply a decrease of -0.69% or -$0.06 in intraday trading. The BHC share’s 52-week high remains $11.46, putting it -33.26% down since that peak but still an impressive 35.23% since price per share fell to its 52-week low of $5.57. The company has a valuation of $3.14B, with an average of 2.82 million shares over the past 3 months.
Bausch Health Companies Inc (NYSE:BHC) trade information
After registering a -0.69% downside in the last session, Bausch Health Companies Inc (BHC) has traded red over the past five days. The stock hit a weekly high of 8.98, dropping -0.69% in its intraday price action. The 5-day price performance for the stock is -4.12%, and -9.85% over 30 days. With these gigs, the year-to-date price performance is 7.23%.
Bausch Health Companies Inc (BHC) estimates and forecasts
Looking at statistics comparing Bausch Health Companies Inc share performance against respective industry, we note that the company has underperformed competitors. Bausch Health Companies Inc (BHC) shares are 10.68% up over the last 6 months, with its year-to-date growth rate lower than industry average at 13.18% against 21.70%. Revenue is forecast to grow 32.70% this quarter before jumping 17.10% for the next one. The rating firms project that company’s revenue will grow 7.20% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is $2.15 billion. Meanwhile, for the quarter ending Jun 2024, a total of 4 analyst(s) estimate revenue growth to $2.35 billion.Earnings reports from the last fiscal year show that sales brought in $1.97 billion and $2.17 billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 9.30% before jumping 8.40% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 32.76% for the past 5-year period. While 2024 is set for a 12.75% return in earnings, projections for the next 5 years are at 2.60% annually.
BHC Dividends
Bausch Health Companies Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Bausch Health Companies Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
